logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5476.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5476.produseast1
Showing 1 - 20 of 84 Items
Showing 1 - 20 of 84 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Diagnostic performance and kinetics of hepatitis E viral RNA and IgM antibody test positivity in a genotype 1 outbreak in South Sudan

Koyuncu A, Nesbitt R, Alvarez C, Asilaza KV, Wamala J,  et al.
2025-08-14 • Journal of Infectious Diseases
2025-08-14 • Journal of Infectious Diseases

BACKGROUND

Diagnostics are essential for understanding hepatitis E epidemiology, but the field performanc...

Conference Material
|
Abstract

Bending the curve of hepatitis C virus infection in Machar Colony: a mass screen-and-treat intervention in a slum settlement in Karachi, Pakistan

Aslam MK, de Glanville WA, Wailly Y, Miazek M, Hamid S,  et al.
2025-05-22 • MSF Scientific Days International 2025
2025-05-22 • MSF Scientific Days International 2025
Conference Material
|
Slide Presentation

Bending the curve of hepatitis C virus infection in Machar Colony: a mass screen-and-treat intervention in a slum settlement in Karachi, Pakistan

Aslam MK, de Glanville WA, Wailly Y, Miazek M, Hamid S,  et al.
2025-05-22 • MSF Scientific Days International 2025
2025-05-22 • MSF Scientific Days International 2025
Journal Article
|
Research

Prevalence of hepatitis C virus seropositivity and active infection in a Rohingya refugee population in Cox's Bazar camps, Bangladesh: a cross-sectional study

Schramm B, Ashakin KA, Firuz W, Hadiuzzaman M, Ben-Farhat J,  et al.
2025-04-01 • Lancet Gastroenterology and Hepatology
2025-04-01 • Lancet Gastroenterology and Hepatology
Journal Article
|
Research

High confidence and demand for hepatitis E vaccine during an outbreak in Bentiu, South Sudan: A qualitative study

Koyuncu A, Asilaza KV, Rumunu J, Wamala J, Gitahi P,  et al.
2025-03-06 • PLOS Global Public Health
2025-03-06 • PLOS Global Public Health

In 2021 in response to an outbreak of hepatitis E in Bentiu internally displaced persons camp the South Sudanese Ministry of Health with support from Médecins Sans Frontières implemen...

Journal Article
|
Research

The effectiveness of two doses of recombinant hepatitis E vaccine in response to an outbreak in Bentiu, South Sudan: a case–control and bias indicator study

Nesbitt RC, Kinya Asilaza V, Alvarez C, Gitahi P, Nkemenang P,  et al.
2025-01-08 • Lancet Infectious Diseases
2025-01-08 • Lancet Infectious Diseases

BACKGROUND

Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis, particularly in Asia and Africa, where HEV genotypes 1 and 2 are prevalen...

Journal Article
|
Research

Safety of hepatitis E vaccine in pregnancy: an emulated target trial following a mass reactive vaccination campaign in Bentiu internally displaced persons camp, South Sudan

Nesbitt RC, Azman AS, Asilaza VK, Edwards JK, Gitahi P,  et al.
2024-11-01 • Lancet Global Health
2024-11-01 • Lancet Global Health
Journal Article
|
Research

Usability and acceptability of self-testing for hepatitis C virus exposure in a high-prevalence urban informal settlement in Karachi, Pakistan

Mazzilli S, Aslam MK, Akhtar J, Miazek M, Wailly Y,  et al.
2024-09-27 • BMC Infectious Diseases
2024-09-27 • BMC Infectious Diseases

BACKGROUND

Hepatitis C virus (HCV) antibody self-testing (HCVST) may help expand screening access and support HCV elimination efforts. Despite potential benefit...

Conference Material
|
Video

A concern for large-scale treatment access: High prevalence of active HCV infection among forcibly displaced Myanmar nationals residing in camps, Cox’s Bazar, Bangladesh

Schramm B
2024-07-01 • Epicentre Scientific Day 2024
2024-07-01 • Epicentre Scientific Day 2024
Conference Material
|
Poster

Prevalence of active hepatitis C virus (HCV) infection and associated factors among forcibly displaced Myanmar nationals residing in camps, Cox’s Bazar, Bangladesh

Ashakin KA, Hadiuzzaman M, Firuz W, Rahman A, Ben-Farhat J,  et al.
2024-05-23 • Epicentre Scientific Day 2024
2024-05-23 • Epicentre Scientific Day 2024
Conference Material
|
Abstract

Hepatitis E outbreak response in Fangak County, South Sudan: coverage and acceptance of a vaccination campaign targeting women of reproductive age

Aumuller J
2024-05-23 • Epicentre Scientific Day 2024
2024-05-23 • Epicentre Scientific Day 2024
BACKGROUND
In September 2023, the South Sudan Ministry of Health declared an outbreak of hepatitis E virus in Fangak County, Jonglei State. From April to November 2023, MSF identifie...
Conference Material
|
Abstract

First mass reactive vaccination campaign against Hepatitis E: main results of observational studies

Gignoux EM
2024-05-23 • Epicentre Scientific Day 2024
2024-05-23 • Epicentre Scientific Day 2024

BACKGROUND

Hepatitis E was first identified in the 1990s, but major epidemics date back to the 1950s. There is no specific treatment, and it can be fatal especially for pregnant...

Conference Material
|
Video

First mass reactive vaccination campaign against Hepatitis E: main results of observational studies

Gignoux EM
2024-05-23 • Epicentre Scientific Day 2024
2024-05-23 • Epicentre Scientific Day 2024
Conference Material
|
Abstract

A concern for large-scale treatment access: High prevalence of active HCV infection among forcibly displaced Myanmar Nationals residing in camps, Cox’s Bazar, Bangladesh

Schramm B, Hossain FN
2024-05-23 • Epicentre Scientific Day 2024
2024-05-23 • Epicentre Scientific Day 2024

BACKGROUND

Hepatitis C virus (HCV) is a major cause of liver diseases globally. Transmission is primarily bloodborne through unsafe injections or healthcare practices. Effective...

Conference Material
|
Video

Safety of hepatitis E vaccine in pregnancy emulating a target trial following a mass reactive vaccination campaign in South Sudan

Gignoux EM
2024-05-16 • MSF Scientific Day International 2024
2024-05-16 • MSF Scientific Day International 2024
Conference Material
|
Slide Presentation

Safety of hepatitis E vaccine in pregnancy: emulating a target trial following a mass reactive vaccination campaign in South Sudan

Nesbitt R, Azman AS, Asilaza VK, Edwards JK, Nkemenang P,  et al.
2024-05-16 • MSF Scientific Day International 2024
2024-05-16 • MSF Scientific Day International 2024
Conference Material
|
Abstract

Safety of hepatitis E vaccine in pregnancy: emulating a target trial following a mass reactive vaccination campaign in South Sudan

Nesbitt R, Azman AS, Asilaza VK, Edwards JK, Nkemenang P,  et al.
2024-05-16 • MSF Scientific Day International 2024
2024-05-16 • MSF Scientific Day International 2024

INTRODUCTION

Hepatitis E causes high mortality among pregnant women, with case fatality risks over 30% and adverse fetal outcomes. There is an evidence gap on the safety of the ...

Conference Material
|
Poster

Evaluation of a simplified model of care for chronic hepatitis C infection in Rohingya population in Ukhiya, Cox’s Bazar, Bangladesh

Firuz W, Ashakin KA, Schramm B, Camelique O, Duka M,  et al.
2024-05-16 • MSF Scientific Day International 2024
2024-05-16 • MSF Scientific Day International 2024
Conference Material
|
Poster

Implementation of a chronic care unit in humanitarian settings: Lessons learned from Malakal, South Sudan

Cuenca P, Skidmore J, Adwok E, Dau S, Nggilari J,  et al.
2024-05-03 • MSF Paediatric Days 2024
2024-05-03 • MSF Paediatric Days 2024
Journal Article
|
Research

Vaccination coverage and adverse events following a reactive vaccination campaign against hepatitis E in Bentiu displaced persons camp, South Sudan

Nesbitt RC, Asilaza VK, Gignoux EM, Koyuncu A, Gitahi P,  et al.
2024-01-22 • PLOS Neglected Tropical Diseases
2024-01-22 • PLOS Neglected Tropical Diseases

INTRODUCTION

Hepatitis E (HEV) genotypes 1 and 2 are the common cause of jaundice and acute viral hepatitis that can cause large-scale outbreaks. HEV infection...